ProCE Banner Activity

ExpressPoints
New Approaches in Urothelial Carcinoma: Expert Guidance to Improve Patient Outcomes

Slideset Download
Download this short summary slideset with key takeaways from a live CCO Webinar focused on data for using immune checkpoint inhibitors for patients with urothelial cancer.

Released: March 03, 2021

Expiration: March 02, 2022

No longer available for credit.

Share

Faculty

Andrea Apolo

Andrea Apolo, MD

Medical Oncology
Bethesda, Maryland

Matthew Galsky

Matthew Galsky, MD

Professor of Medicine
Director of Genitourinary Medical Oncology
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, New York

Elizabeth Plimack

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer and EMD Serono

Faculty Disclosure

Primary Author

Andrea Apolo, MD

Medical Oncology
Bethesda, Maryland

Matthew Galsky, MD

Professor of Medicine
Director of Genitourinary Medical Oncology
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, New York

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania